Author

S. Jalaguier

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:bulk RNA-seq· 2 Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Organism:mouse· 1

Frequent Co-Authors

V. Cavailles· 3 shared C. Teyssier· 2 shared S. Bonnet· 2 shared A. Castet-Nicolas· 1 shared A. Dulom· 1 shared A. Kuehn· 1 shared A. Maraver· 1 shared B. Gyorffy· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 23 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

V. Cavailles

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

The transcription factor RIP140 regulates interferon γ signaling in breast cancer

S. Jalaguier, A. Kuehn, C. Petitpas, A. Dulom, R. Jacquemont, C. Assi, S. Sixou, U. Jeschke, J. Colinge, V. Cavailles

This study identifies RIP140 as a regulator of IFNγ signaling in breast cancer, showing its repression of IFNγ-induced GBP1 expression and its role in enhancing IFNγ's anti-tumor effects.

bioRxiv · Feb 15, 2024Cancer Biology

RIP140 regulates HES1 oscillatory expression and mitogenic activity in colon cancer cells

N. Sfeir, M. Kajdan, S. Jalaguier, S. Bonnet, C. Teyssier, S. Pyrdziak, R. Yuan, E. Bousquet, A. Maraver, F. Bernex, N. Pirot, F. Boissiere, A. Castet-Nicolas, M. Lapierre, V. Cavailles

This study shows RIP140 regulates HES1 expression and mitogenic activity in colon cancer cells, with implications for patient survival.

bioRxiv · May 13, 2023 · PreprintCancer Biology

RIP140 inhibits glycolysis-dependent proliferation of breast cancer cells by regulating GLUT3 expression through transcriptional crosstalk between hypoxia induced factor and p53

V. Jacquier, D. Gitenay, S. Fritsch, B. Gyorffy, S. Bonnet, S. Jalaguier, L. K. Linares, V. Cavailles, C. Teyssier

This study shows RIP140 inhibits breast cancer cell glycolysis and proliferation by reducing GLUT3 expression through interaction with HIF-2 and p53.

bioRxiv · Jul 30, 2020Cancer Biology